Rank | Gene Set | Z-score |
---|---|---|
1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.29950171 |
2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.29950171 |
3 | modulation by symbiont of host immune response (GO:0052553) | 4.29950171 |
4 | positive regulation by symbiont of host defense response (GO:0052509) | 4.29950171 |
5 | modulation by symbiont of host defense response (GO:0052031) | 4.29950171 |
6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.29950171 |
7 | synaptic vesicle maturation (GO:0016188) | 4.13405091 |
8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.05635500 |
9 | response to peptidoglycan (GO:0032494) | 4.03983502 |
10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.00170053 |
11 | macrophage activation involved in immune response (GO:0002281) | 4.00093116 |
12 | detection of other organism (GO:0098543) | 3.95861958 |
13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.84072101 |
14 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.78150629 |
15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.76658649 |
16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.75778074 |
17 | locomotory exploration behavior (GO:0035641) | 3.74912199 |
18 | neutrophil activation involved in immune response (GO:0002283) | 3.73029571 |
19 | detection of bacterium (GO:0016045) | 3.70597111 |
20 | detection of molecule of bacterial origin (GO:0032490) | 3.57234051 |
21 | negative regulation of interleukin-12 production (GO:0032695) | 3.54870373 |
22 | layer formation in cerebral cortex (GO:0021819) | 3.53106316 |
23 | detection of external biotic stimulus (GO:0098581) | 3.49577154 |
24 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.46363302 |
25 | cellular extravasation (GO:0045123) | 3.45984814 |
26 | vocalization behavior (GO:0071625) | 3.42644919 |
27 | synaptic vesicle exocytosis (GO:0016079) | 3.36701875 |
28 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.30162393 |
29 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.29553170 |
30 | activation of protein kinase A activity (GO:0034199) | 3.26375789 |
31 | sodium ion export (GO:0071436) | 3.24209799 |
32 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.23840043 |
33 | glutamate secretion (GO:0014047) | 3.12488957 |
34 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.12100209 |
35 | detection of biotic stimulus (GO:0009595) | 3.07272557 |
36 | cellular potassium ion homeostasis (GO:0030007) | 3.04259225 |
37 | regulation of synapse structural plasticity (GO:0051823) | 3.01326729 |
38 | proline transport (GO:0015824) | 2.99856418 |
39 | regulation of leukocyte degranulation (GO:0043300) | 2.98330281 |
40 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.97749315 |
41 | regulation of mast cell degranulation (GO:0043304) | 2.96144268 |
42 | regulation of gamma-delta T cell activation (GO:0046643) | 2.94864535 |
43 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.93629909 |
44 | germinal center formation (GO:0002467) | 2.92243102 |
45 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.91919133 |
46 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.89680775 |
47 | macrophage activation (GO:0042116) | 2.89354926 |
48 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.87405809 |
49 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.86258061 |
50 | exploration behavior (GO:0035640) | 2.85268307 |
51 | response to muramyl dipeptide (GO:0032495) | 2.84650282 |
52 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.84542899 |
53 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.83720559 |
54 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.83395011 |
55 | response to host immune response (GO:0052572) | 2.83395011 |
56 | immunoglobulin mediated immune response (GO:0016064) | 2.82084229 |
57 | dendrite morphogenesis (GO:0048813) | 2.81884589 |
58 | regulation of ARF protein signal transduction (GO:0032012) | 2.81550924 |
59 | regulation of synaptic vesicle transport (GO:1902803) | 2.79314850 |
60 | response to host (GO:0075136) | 2.79056876 |
61 | response to host defenses (GO:0052200) | 2.79056876 |
62 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.79056876 |
63 | neurotransmitter secretion (GO:0007269) | 2.78241337 |
64 | granulocyte activation (GO:0036230) | 2.77023887 |
65 | neutrophil activation (GO:0042119) | 2.74377744 |
66 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.71559185 |
67 | leukocyte aggregation (GO:0070486) | 2.70876761 |
68 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.67303711 |
69 | microglial cell activation (GO:0001774) | 2.67135588 |
70 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.64159460 |
71 | myeloid cell activation involved in immune response (GO:0002275) | 2.62967105 |
72 | mannose metabolic process (GO:0006013) | 2.60998461 |
73 | response to type I interferon (GO:0034340) | 2.58677005 |
74 | type I interferon signaling pathway (GO:0060337) | 2.58232487 |
75 | cellular response to type I interferon (GO:0071357) | 2.58232487 |
76 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.57521960 |
77 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.57182160 |
78 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.57034777 |
79 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.56810994 |
80 | protein localization to synapse (GO:0035418) | 2.55444570 |
81 | response to laminar fluid shear stress (GO:0034616) | 2.54793055 |
82 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.54601082 |
83 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.53186719 |
84 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.51754330 |
85 | regulation of regulated secretory pathway (GO:1903305) | 2.51694950 |
86 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.51571476 |
87 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.51450577 |
88 | regulation of T cell tolerance induction (GO:0002664) | 2.50860298 |
89 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.49652359 |
90 | positive regulation of mast cell activation (GO:0033005) | 2.49567073 |
91 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.48804087 |
92 | regulation of tolerance induction (GO:0002643) | 2.47535374 |
93 | positive regulation of leukocyte degranulation (GO:0043302) | 2.46766971 |
94 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.46720768 |
95 | dendritic spine morphogenesis (GO:0060997) | 2.46053662 |
96 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.45554359 |
97 | nucleobase catabolic process (GO:0046113) | 2.45206357 |
98 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.44713066 |
99 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.44678742 |
100 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.43327162 |
101 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.42469930 |
102 | protein targeting to Golgi (GO:0000042) | 2.42072238 |
103 | clathrin coat assembly (GO:0048268) | 2.41799986 |
104 | respiratory burst (GO:0045730) | 2.41237087 |
105 | neuron cell-cell adhesion (GO:0007158) | 2.41189239 |
106 | barbed-end actin filament capping (GO:0051016) | 2.40420580 |
107 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.40385074 |
108 | T-helper 1 type immune response (GO:0042088) | 2.40131308 |
109 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.38865380 |
110 | regulation of mast cell activation (GO:0033003) | 2.37480679 |
111 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.37407235 |
112 | mating behavior (GO:0007617) | 2.37250309 |
113 | alanine transport (GO:0032328) | 2.36913391 |
114 | stress fiber assembly (GO:0043149) | 2.36823880 |
115 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.36558109 |
116 | negative regulation of cell killing (GO:0031342) | 2.36134351 |
117 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.36134351 |
118 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.35914037 |
119 | cell communication by electrical coupling (GO:0010644) | 2.35328686 |
120 | negative regulation of interleukin-6 production (GO:0032715) | 2.35155252 |
121 | positive regulation of type 2 immune response (GO:0002830) | 2.34747494 |
122 | regulation of macrophage cytokine production (GO:0010935) | 2.34533376 |
123 | Golgi transport vesicle coating (GO:0048200) | 2.34519765 |
124 | COPI coating of Golgi vesicle (GO:0048205) | 2.34519765 |
125 | nerve growth factor signaling pathway (GO:0038180) | 2.34252437 |
126 | cerebellar Purkinje cell layer development (GO:0021680) | 2.33764156 |
127 | gamma-aminobutyric acid transport (GO:0015812) | 2.33635976 |
128 | glycosphingolipid catabolic process (GO:0046479) | 2.33514193 |
129 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.33083907 |
130 | neuron recognition (GO:0008038) | 2.32670371 |
131 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.32047143 |
132 | establishment of protein localization to Golgi (GO:0072600) | 2.31942584 |
133 | regulation of type 2 immune response (GO:0002828) | 2.31732129 |
134 | negative regulation of T cell mediated immunity (GO:0002710) | 2.29315840 |
135 | potassium ion import (GO:0010107) | 2.28949369 |
136 | pinocytosis (GO:0006907) | 2.27884682 |
137 | NIK/NF-kappaB signaling (GO:0038061) | 2.27392599 |
138 | positive regulation of receptor recycling (GO:0001921) | 2.26389553 |
139 | negative regulation of type 2 immune response (GO:0002829) | 2.25121766 |
140 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.24969479 |
141 | negative regulation of innate immune response (GO:0045824) | 2.24968161 |
142 | regulation of antigen processing and presentation (GO:0002577) | 2.23887058 |
143 | myeloid dendritic cell differentiation (GO:0043011) | 2.22744089 |
144 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.22623264 |
145 | positive regulation of mast cell degranulation (GO:0043306) | 2.21760672 |
146 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.21760672 |
147 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.21309259 |
148 | protein localization to endosome (GO:0036010) | 2.20558425 |
149 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.19340813 |
150 | innervation (GO:0060384) | 2.19113749 |
151 | positive regulation of vesicle fusion (GO:0031340) | 2.18901773 |
152 | neuromuscular process controlling balance (GO:0050885) | 2.18394824 |
153 | positive regulation of axon extension (GO:0045773) | 2.17792322 |
154 | positive regulation of synapse maturation (GO:0090129) | 2.16993415 |
155 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.14545198 |
156 | glycine transport (GO:0015816) | 2.13332400 |
157 | vesicle transport along microtubule (GO:0047496) | 2.13019060 |
158 | regulation of vesicle fusion (GO:0031338) | 2.12962966 |
159 | axonal fasciculation (GO:0007413) | 2.12528326 |
160 | cell communication involved in cardiac conduction (GO:0086065) | 2.11759207 |
161 | cellular sodium ion homeostasis (GO:0006883) | 2.11428422 |
162 | potassium ion homeostasis (GO:0055075) | 2.10445566 |
163 | establishment of nucleus localization (GO:0040023) | 2.09729198 |
164 | regulation of ARF GTPase activity (GO:0032312) | 2.09264757 |
165 | prepulse inhibition (GO:0060134) | 2.09022270 |
166 | neurotransmitter transport (GO:0006836) | 2.08321780 |
167 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.06943440 |
168 | axon extension (GO:0048675) | 2.06871480 |
169 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.06589860 |
170 | axon cargo transport (GO:0008088) | 2.06468773 |
171 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.06466827 |
172 | long-term memory (GO:0007616) | 2.05440070 |
173 | synaptic vesicle endocytosis (GO:0048488) | 2.05223081 |
174 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.04650294 |
175 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.04504552 |
176 | positive regulation of membrane potential (GO:0045838) | 2.03235844 |
177 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.03005277 |
178 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.02012954 |
179 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.01570279 |
180 | regulation of synaptic plasticity (GO:0048167) | 2.00461195 |
181 | protein targeting to plasma membrane (GO:0072661) | 1.99681445 |
182 | response to auditory stimulus (GO:0010996) | 1.99365914 |
183 | signal complex assembly (GO:0007172) | 1.99235549 |
184 | regulation of clathrin-mediated endocytosis (GO:2000369) | 1.98769028 |
185 | long-term synaptic potentiation (GO:0060291) | 1.98492273 |
186 | cell migration in hindbrain (GO:0021535) | 1.97993857 |
187 | macroautophagy (GO:0016236) | 1.97603812 |
188 | organelle transport along microtubule (GO:0072384) | 1.97066486 |
189 | dopamine receptor signaling pathway (GO:0007212) | 1.97027992 |
190 | synapse assembly (GO:0007416) | 1.97003388 |
191 | cellular response to glucagon stimulus (GO:0071377) | 1.95970939 |
192 | glutamate receptor signaling pathway (GO:0007215) | 1.95919783 |
193 | regulation of dendritic spine morphogenesis (GO:0061001) | 1.95876889 |
194 | suckling behavior (GO:0001967) | 1.95155574 |
195 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 1.94319648 |
196 | adenosine receptor signaling pathway (GO:0001973) | 1.94223898 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.60625525 |
2 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.79523707 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.75996315 |
4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.62755782 |
5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.62257019 |
6 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.47290233 |
7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.45049720 |
8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.43225432 |
9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.38502160 |
10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.24497222 |
11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.19706397 |
12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.16089460 |
13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.14404620 |
14 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.14074670 |
15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.13209204 |
16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.11935060 |
17 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.08304343 |
18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.99391119 |
19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.97252382 |
20 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.93959815 |
21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.91595872 |
22 | SPI1_23127762_ChIP-Seq_K562_Human | 1.89219635 |
23 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.89035465 |
24 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.89035465 |
25 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.87176730 |
26 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.86708893 |
27 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.86569973 |
28 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.84612244 |
29 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.83913813 |
30 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.81517366 |
31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.77008582 |
32 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.73978063 |
33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70736947 |
34 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.69342395 |
35 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.68865363 |
36 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.67695744 |
37 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.67503377 |
38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.67395329 |
39 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.67129210 |
40 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.65771076 |
41 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.65136934 |
42 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.65013600 |
43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.64973508 |
44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.59908617 |
45 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.59883071 |
46 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.58396722 |
47 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.56519564 |
48 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.56512132 |
49 | * MAF_26560356_Chip-Seq_TH1_Human | 1.54106368 |
50 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.53070741 |
51 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.52876299 |
52 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.51383416 |
53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.50797978 |
54 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.50481054 |
55 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.49734955 |
56 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.47665719 |
57 | MYC_22102868_ChIP-Seq_BL_Human | 1.45692297 |
58 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.45474984 |
59 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.45454487 |
60 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.45081631 |
61 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.42408783 |
62 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.42065059 |
63 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.40660374 |
64 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.39830439 |
65 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.38698915 |
66 | KDM2B_26808549_Chip-Seq_K562_Human | 1.36474841 |
67 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.35865345 |
68 | GATA1_19941826_ChIP-Seq_K562_Human | 1.33000403 |
69 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.32183050 |
70 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.31069661 |
71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30623109 |
72 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.30549453 |
73 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29216672 |
74 | UTX_26944678_Chip-Seq_JUKART_Human | 1.29140797 |
75 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.29016792 |
76 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.28810657 |
77 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.28431953 |
78 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27489439 |
79 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.26631908 |
80 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.26284497 |
81 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.23744186 |
82 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.22894753 |
83 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22483922 |
84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.22436920 |
85 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21709982 |
86 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.21384739 |
87 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20928180 |
88 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20792850 |
89 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20716470 |
90 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.19010785 |
91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19001455 |
92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16435527 |
93 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14774426 |
94 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.14075365 |
95 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13904758 |
96 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.13858888 |
97 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13509724 |
98 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11514490 |
99 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.10998675 |
100 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.10983317 |
101 | RXR_22108803_ChIP-Seq_LS180_Human | 1.10740603 |
102 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10408567 |
103 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09569634 |
104 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09328637 |
105 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.09252188 |
106 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.08934845 |
107 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08484512 |
108 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.08194759 |
109 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.07928816 |
110 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06532488 |
111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05919351 |
112 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05066406 |
113 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.04763585 |
114 | MAF_26560356_Chip-Seq_TH2_Human | 1.04263869 |
115 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03789839 |
116 | MYB_26560356_Chip-Seq_TH2_Human | 1.03686722 |
117 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03652481 |
118 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02456703 |
119 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.02218439 |
120 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.02112469 |
121 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01044848 |
122 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01038674 |
123 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00521620 |
124 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99813262 |
125 | MYB_26560356_Chip-Seq_TH1_Human | 0.98919338 |
126 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.98731640 |
127 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98669838 |
128 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98669838 |
129 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98471000 |
130 | AR_19668381_ChIP-Seq_PC3_Human | 0.98368452 |
131 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98151942 |
132 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97981080 |
133 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97981080 |
134 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97958706 |
135 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97037327 |
136 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96769097 |
137 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96646327 |
138 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.95995055 |
139 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.95891254 |
140 | AR_25329375_ChIP-Seq_VCAP_Human | 0.95823888 |
141 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.95168098 |
142 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95026909 |
143 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94593923 |
144 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.94282994 |
145 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94281320 |
146 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.92743566 |
147 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92668149 |
148 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91629828 |
149 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.91243860 |
150 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.90942500 |
151 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.90799005 |
152 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.90434671 |
153 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.90190963 |
154 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.89867177 |
155 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.88239708 |
156 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.87470109 |
157 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.87153934 |
158 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.87134840 |
159 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.86240497 |
160 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.84828666 |
161 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.83267631 |
162 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82260718 |
163 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.81833845 |
164 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.81822448 |
165 | STAT3_23295773_ChIP-Seq_U87_Human | 0.80867539 |
166 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.80796839 |
167 | TP53_16413492_ChIP-PET_HCT116_Human | 0.80594182 |
168 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80154912 |
169 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.79961402 |
170 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.79612392 |
171 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78951958 |
172 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.78745616 |
173 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.78135873 |
174 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.77389539 |
175 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.77161055 |
176 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.76824923 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 4.65692376 |
2 | MP0003436_decreased_susceptibility_to | 3.50836529 |
3 | MP0003724_increased_susceptibility_to | 3.45214686 |
4 | MP0009780_abnormal_chondrocyte_physiolo | 3.44591624 |
5 | MP0004270_analgesia | 2.93705752 |
6 | MP0003635_abnormal_synaptic_transmissio | 2.85264916 |
7 | MP0001835_abnormal_antigen_presentation | 2.60591321 |
8 | MP0002419_abnormal_innate_immunity | 2.51248448 |
9 | MP0009840_abnormal_foam_cell | 2.49385813 |
10 | MP0006082_CNS_inflammation | 2.45561095 |
11 | MP0002909_abnormal_adrenal_gland | 2.38620363 |
12 | MP0003329_amyloid_beta_deposits | 2.27041896 |
13 | MP0002063_abnormal_learning/memory/cond | 2.24177226 |
14 | MP0005025_abnormal_response_to | 2.23290482 |
15 | MP0009785_altered_susceptibility_to | 2.21834861 |
16 | MP0000685_abnormal_immune_system | 2.19362185 |
17 | MP0000013_abnormal_adipose_tissue | 2.16953149 |
18 | MP0005387_immune_system_phenotype | 2.16786046 |
19 | MP0001790_abnormal_immune_system | 2.16786046 |
20 | MP0001533_abnormal_skeleton_physiology | 2.12218903 |
21 | MP0004858_abnormal_nervous_system | 2.11710709 |
22 | MP0005000_abnormal_immune_tolerance | 2.11196901 |
23 | MP0002148_abnormal_hypersensitivity_rea | 2.05834350 |
24 | MP0005451_abnormal_body_composition | 2.03909883 |
25 | MP0003880_abnormal_central_pattern | 2.00878688 |
26 | MP0002064_seizures | 1.95722206 |
27 | MP0009745_abnormal_behavioral_response | 1.93395497 |
28 | MP0005671_abnormal_response_to | 1.85087349 |
29 | MP0001800_abnormal_humoral_immune | 1.84683636 |
30 | MP0003828_pulmonary_edema | 1.84143935 |
31 | MP0002452_abnormal_antigen_presenting | 1.82431489 |
32 | MP0008961_abnormal_basal_metabolism | 1.81677297 |
33 | MP0003300_gastrointestinal_ulcer | 1.79632309 |
34 | MP0002723_abnormal_immune_serum | 1.78324191 |
35 | MP0005423_abnormal_somatic_nervous | 1.77837541 |
36 | MP0008260_abnormal_autophagy | 1.77673233 |
37 | MP0009046_muscle_twitch | 1.77269032 |
38 | MP0005464_abnormal_platelet_physiology | 1.76046129 |
39 | MP0000604_amyloidosis | 1.75444629 |
40 | MP0003303_peritoneal_inflammation | 1.75286153 |
41 | MP0000569_abnormal_digit_pigmentation | 1.74732179 |
42 | MP0003045_fibrosis | 1.72182351 |
43 | MP0002998_abnormal_bone_remodeling | 1.71801832 |
44 | MP0010155_abnormal_intestine_physiology | 1.71188251 |
45 | MP0003172_abnormal_lysosome_physiology | 1.69309158 |
46 | MP0002734_abnormal_mechanical_nocicepti | 1.68643260 |
47 | MP0002420_abnormal_adaptive_immunity | 1.66781094 |
48 | MP0001819_abnormal_immune_cell | 1.66156299 |
49 | MP0002572_abnormal_emotion/affect_behav | 1.64638637 |
50 | MP0001968_abnormal_touch/_nociception | 1.62852869 |
51 | MP0003183_abnormal_peptide_metabolism | 1.62037143 |
52 | MP0004130_abnormal_muscle_cell | 1.61961565 |
53 | MP0001348_abnormal_lacrimal_gland | 1.57719226 |
54 | MP0010234_abnormal_vibrissa_follicle | 1.57334368 |
55 | MP0003566_abnormal_cell_adhesion | 1.56518242 |
56 | MP0009278_abnormal_bone_marrow | 1.54281806 |
57 | MP0000858_altered_metastatic_potential | 1.46974101 |
58 | MP0002837_dystrophic_cardiac_calcinosis | 1.46458847 |
59 | MP0001845_abnormal_inflammatory_respons | 1.46382468 |
60 | MP0008569_lethality_at_weaning | 1.45242784 |
61 | MP0002405_respiratory_system_inflammati | 1.40553023 |
62 | MP0002733_abnormal_thermal_nociception | 1.39973150 |
63 | MP0004811_abnormal_neuron_physiology | 1.39265706 |
64 | MP0003690_abnormal_glial_cell | 1.39245804 |
65 | MP0000343_altered_response_to | 1.38507949 |
66 | MP0002735_abnormal_chemical_nociception | 1.38163871 |
67 | MP0003075_altered_response_to | 1.33747285 |
68 | MP0004043_abnormal_pH_regulation | 1.31723405 |
69 | MP0005058_abnormal_lysosome_morphology | 1.31277757 |
70 | MP0005409_darkened_coat_color | 1.30100960 |
71 | MP0003279_aneurysm | 1.28497662 |
72 | MP0003633_abnormal_nervous_system | 1.28090536 |
73 | MP0003453_abnormal_keratinocyte_physiol | 1.26040848 |
74 | MP0005164_abnormal_response_to | 1.25867407 |
75 | MP0001970_abnormal_pain_threshold | 1.25809585 |
76 | MP0003879_abnormal_hair_cell | 1.25318324 |
77 | MP0001501_abnormal_sleep_pattern | 1.24922871 |
78 | MP0008469_abnormal_protein_level | 1.24418310 |
79 | MP0001486_abnormal_startle_reflex | 1.24216541 |
80 | MP0009764_decreased_sensitivity_to | 1.23301156 |
81 | MP0002272_abnormal_nervous_system | 1.23264818 |
82 | MP0004883_abnormal_blood_vessel | 1.21020936 |
83 | MP0000778_abnormal_nervous_system | 1.20897970 |
84 | MP0009333_abnormal_splenocyte_physiolog | 1.18312376 |
85 | MP0002090_abnormal_vision | 1.17566970 |
86 | MP0003448_altered_tumor_morphology | 1.17456866 |
87 | MP0000716_abnormal_immune_system | 1.16496892 |
88 | MP0002184_abnormal_innervation | 1.15253238 |
89 | MP0004510_myositis | 1.14095463 |
90 | MP0010386_abnormal_urinary_bladder | 1.13267460 |
91 | MP0001851_eye_inflammation | 1.12904739 |
92 | MP0003866_abnormal_defecation | 1.12226065 |
93 | MP0003763_abnormal_thymus_physiology | 1.10172353 |
94 | MP0001440_abnormal_grooming_behavior | 1.09401453 |
95 | MP0004885_abnormal_endolymph | 1.09051507 |
96 | MP0000465_gastrointestinal_hemorrhage | 1.07956830 |
97 | MP0005390_skeleton_phenotype | 1.07686142 |
98 | MP0002557_abnormal_social/conspecific_i | 1.06332029 |
99 | MP0002736_abnormal_nociception_after | 1.05564774 |
100 | MP0001299_abnormal_eye_distance/ | 1.04488692 |
101 | MP0002067_abnormal_sensory_capabilities | 1.04230752 |
102 | MP0008004_abnormal_stomach_pH | 1.04077502 |
103 | MP0005623_abnormal_meninges_morphology | 1.03912642 |
104 | MP0005535_abnormal_body_temperature | 1.03843130 |
105 | MP0005023_abnormal_wound_healing | 1.03739978 |
106 | MP0001849_ear_inflammation | 1.02418931 |
107 | MP0000003_abnormal_adipose_tissue | 1.02389158 |
108 | MP0000955_abnormal_spinal_cord | 1.00751183 |
109 | MP0002398_abnormal_bone_marrow | 1.00327473 |
110 | MP0005076_abnormal_cell_differentiation | 0.99928279 |
111 | MP0001545_abnormal_hematopoietic_system | 0.99548894 |
112 | MP0005397_hematopoietic_system_phenotyp | 0.99548894 |
113 | MP0001765_abnormal_ion_homeostasis | 0.96087964 |
114 | MP0000920_abnormal_myelination | 0.95378313 |
115 | MP0001502_abnormal_circadian_rhythm | 0.95223345 |
116 | MP0001853_heart_inflammation | 0.95222135 |
117 | MP0003252_abnormal_bile_duct | 0.94628703 |
118 | MP0003634_abnormal_glial_cell | 0.94517151 |
119 | MP0003631_nervous_system_phenotype | 0.93822932 |
120 | MP0001984_abnormal_olfaction | 0.92829374 |
121 | MP0000249_abnormal_blood_vessel | 0.91983718 |
122 | MP0000767_abnormal_smooth_muscle | 0.91758788 |
123 | MP0002822_catalepsy | 0.91593157 |
124 | MP0008874_decreased_physiological_sensi | 0.90996652 |
125 | MP0005310_abnormal_salivary_gland | 0.88908134 |
126 | MP0002254_reproductive_system_inflammat | 0.87500607 |
127 | MP0002429_abnormal_blood_cell | 0.87264673 |
128 | MP0005386_behavior/neurological_phenoty | 0.86811329 |
129 | MP0004924_abnormal_behavior | 0.86811329 |
130 | MP0002066_abnormal_motor_capabilities/c | 0.86754333 |
131 | MP0002132_abnormal_respiratory_system | 0.86266435 |
132 | MP0005167_abnormal_blood-brain_barrier | 0.86131536 |
133 | MP0002933_joint_inflammation | 0.85111870 |
134 | MP0003091_abnormal_cell_migration | 0.84486733 |
135 | MP0002896_abnormal_bone_mineralization | 0.84352295 |
136 | MP0005165_increased_susceptibility_to | 0.84061332 |
137 | MP0002882_abnormal_neuron_morphology | 0.83474474 |
138 | MP0005365_abnormal_bile_salt | 0.83462288 |
139 | MP0003283_abnormal_digestive_organ | 0.83072879 |
140 | MP0004381_abnormal_hair_follicle | 0.82579912 |
141 | MP0008438_abnormal_cutaneous_collagen | 0.82330905 |
142 | MP0003795_abnormal_bone_structure | 0.82189433 |
143 | MP0005360_urolithiasis | 0.81110330 |
144 | MP0002722_abnormal_immune_system | 0.80513015 |
145 | MP0000689_abnormal_spleen_morphology | 0.80028980 |
146 | MP0010329_abnormal_lipoprotein_level | 0.77628416 |
147 | MP0001177_atelectasis | 0.77368770 |
148 | MP0002139_abnormal_hepatobiliary_system | 0.77138005 |
149 | MP0002876_abnormal_thyroid_physiology | 0.76918716 |
150 | MP0000751_myopathy | 0.76756520 |
151 | MP0002078_abnormal_glucose_homeostasis | 0.76112361 |
152 | MP0006054_spinal_hemorrhage | 0.75543712 |
153 | MP0003191_abnormal_cellular_cholesterol | 0.75238599 |
154 | MP0004264_abnormal_extraembryonic_tissu | 0.75219698 |
155 | MP0001663_abnormal_digestive_system | 0.74924091 |
156 | MP0002796_impaired_skin_barrier | 0.73541104 |
157 | MP0002069_abnormal_eating/drinking_beha | 0.73152956 |
158 | MP0004947_skin_inflammation | 0.72812851 |
159 | MP0001958_emphysema | 0.71937757 |
160 | MP0003705_abnormal_hypodermis_morpholog | 0.71007350 |
161 | MP0004185_abnormal_adipocyte_glucose | 0.70824612 |
162 | MP0009763_increased_sensitivity_to | 0.69221277 |
163 | MP0001756_abnormal_urination | 0.68293869 |
164 | MP0005448_abnormal_energy_balance | 0.67530157 |
165 | MP0005275_abnormal_skin_tensile | 0.67321588 |
166 | MP0001542_abnormal_bone_strength | 0.66414573 |
167 | MP0005166_decreased_susceptibility_to | 0.65756473 |
168 | MP0003632_abnormal_nervous_system | 0.65412777 |
169 | MP0002168_other_aberrant_phenotype | 0.64595592 |
170 | MP0002877_abnormal_melanocyte_morpholog | 0.64274602 |
171 | MP0005375_adipose_tissue_phenotype | 0.64148194 |
172 | MP0002229_neurodegeneration | 0.63874037 |
173 | MP0004085_abnormal_heartbeat | 0.62560476 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 4.94165886 |
2 | Abnormality of macrophages (HP:0004311) | 4.33426866 |
3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.04479109 |
4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.04479109 |
5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.04479109 |
6 | Recurrent abscess formation (HP:0002722) | 3.94978386 |
7 | Recurrent bacterial skin infections (HP:0005406) | 3.92068556 |
8 | Myositis (HP:0100614) | 3.76377032 |
9 | Orchitis (HP:0100796) | 3.73842268 |
10 | Supranuclear gaze palsy (HP:0000605) | 3.58519594 |
11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.46470562 |
12 | Visual hallucinations (HP:0002367) | 3.28900518 |
13 | Focal seizures (HP:0007359) | 3.23199432 |
14 | Retrobulbar optic neuritis (HP:0100654) | 3.20136916 |
15 | Optic neuritis (HP:0100653) | 3.20136916 |
16 | Papilledema (HP:0001085) | 3.19786400 |
17 | Myokymia (HP:0002411) | 3.11521402 |
18 | Systemic lupus erythematosus (HP:0002725) | 3.11074188 |
19 | Focal motor seizures (HP:0011153) | 3.05704381 |
20 | Amyloidosis (HP:0011034) | 2.99200759 |
21 | Cerebral inclusion bodies (HP:0100314) | 2.94568405 |
22 | Neurofibrillary tangles (HP:0002185) | 2.87702496 |
23 | Spontaneous hematomas (HP:0007420) | 2.84458694 |
24 | Action tremor (HP:0002345) | 2.79520345 |
25 | Gingivitis (HP:0000230) | 2.78731276 |
26 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.74784565 |
27 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.74236867 |
28 | Absence seizures (HP:0002121) | 2.73822519 |
29 | Atonic seizures (HP:0010819) | 2.71419300 |
30 | Loss of speech (HP:0002371) | 2.69050538 |
31 | Vacuolated lymphocytes (HP:0001922) | 2.67517895 |
32 | Mediastinal lymphadenopathy (HP:0100721) | 2.66932604 |
33 | Epileptic encephalopathy (HP:0200134) | 2.66473133 |
34 | Stomatitis (HP:0010280) | 2.62523346 |
35 | Increased IgE level (HP:0003212) | 2.59148289 |
36 | Agitation (HP:0000713) | 2.58656687 |
37 | Recurrent skin infections (HP:0001581) | 2.58324164 |
38 | Dysostosis multiplex (HP:0000943) | 2.52675729 |
39 | Cerebral aneurysm (HP:0004944) | 2.49357846 |
40 | Recurrent fungal infections (HP:0002841) | 2.49179093 |
41 | Peritonitis (HP:0002586) | 2.46094712 |
42 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.45949872 |
43 | Gastrointestinal infarctions (HP:0005244) | 2.45067369 |
44 | Ankle clonus (HP:0011448) | 2.42485673 |
45 | Macroorchidism (HP:0000053) | 2.40583926 |
46 | Progressive cerebellar ataxia (HP:0002073) | 2.36007530 |
47 | Malnutrition (HP:0004395) | 2.35437632 |
48 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.34946756 |
49 | Mucopolysacchariduria (HP:0008155) | 2.34946756 |
50 | Cellulitis (HP:0100658) | 2.34302925 |
51 | Obstructive lung disease (HP:0006536) | 2.33185796 |
52 | Chronic obstructive pulmonary disease (HP:0006510) | 2.33185796 |
53 | Purpura (HP:0000979) | 2.32918764 |
54 | Mutism (HP:0002300) | 2.30313013 |
55 | Keratoconjunctivitis sicca (HP:0001097) | 2.29174499 |
56 | Impaired social interactions (HP:0000735) | 2.27986624 |
57 | Abnormal social behavior (HP:0012433) | 2.27986624 |
58 | Hypercortisolism (HP:0001578) | 2.27138278 |
59 | Asymmetric septal hypertrophy (HP:0001670) | 2.26856830 |
60 | Vasculitis (HP:0002633) | 2.26334149 |
61 | Pulmonary infiltrates (HP:0002113) | 2.25893250 |
62 | Dialeptic seizures (HP:0011146) | 2.23056992 |
63 | Gingival bleeding (HP:0000225) | 2.21176788 |
64 | Generalized tonic-clonic seizures (HP:0002069) | 2.20926659 |
65 | Urticaria (HP:0001025) | 2.20857316 |
66 | Abnormal eating behavior (HP:0100738) | 2.19995398 |
67 | Myocardial infarction (HP:0001658) | 2.19644176 |
68 | Hemiplegia (HP:0002301) | 2.19632233 |
69 | Hand muscle atrophy (HP:0009130) | 2.19271418 |
70 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.19265382 |
71 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.19265382 |
72 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.19265382 |
73 | Meningitis (HP:0001287) | 2.19081417 |
74 | Distal upper limb amyotrophy (HP:0007149) | 2.18897474 |
75 | Upper limb amyotrophy (HP:0009129) | 2.18897474 |
76 | Hemoptysis (HP:0002105) | 2.17238606 |
77 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.16202084 |
78 | Vertebral compression fractures (HP:0002953) | 2.14559891 |
79 | Truncal ataxia (HP:0002078) | 2.13888404 |
80 | Depression (HP:0000716) | 2.12828482 |
81 | Arterial tortuosity (HP:0005116) | 2.12314394 |
82 | Prolonged bleeding time (HP:0003010) | 2.09828963 |
83 | Recurrent cutaneous fungal infections (HP:0011370) | 2.09571957 |
84 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.09571957 |
85 | Hemorrhage of the eye (HP:0011885) | 2.09533376 |
86 | Epistaxis (HP:0000421) | 2.08531010 |
87 | Torticollis (HP:0000473) | 2.07102190 |
88 | Genetic anticipation (HP:0003743) | 2.05922097 |
89 | Interstitial pulmonary disease (HP:0006530) | 2.04422853 |
90 | Keratoconjunctivitis (HP:0001096) | 2.02923806 |
91 | Poor eye contact (HP:0000817) | 2.02429873 |
92 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.01976888 |
93 | Pustule (HP:0200039) | 2.01194716 |
94 | Vascular tortuosity (HP:0004948) | 2.01063341 |
95 | Postural instability (HP:0002172) | 2.00658382 |
96 | Increased cerebral lipofuscin (HP:0011813) | 1.99725888 |
97 | Episodic fever (HP:0001954) | 1.99545096 |
98 | Glomerulonephritis (HP:0000099) | 1.96654645 |
99 | Axonal loss (HP:0003447) | 1.96154685 |
100 | Thin bony cortex (HP:0002753) | 1.95838971 |
101 | Striae distensae (HP:0001065) | 1.95635049 |
102 | Arterial thrombosis (HP:0004420) | 1.95633464 |
103 | Intention tremor (HP:0002080) | 1.95596193 |
104 | Urinary urgency (HP:0000012) | 1.94674289 |
105 | Chest pain (HP:0100749) | 1.93663094 |
106 | Febrile seizures (HP:0002373) | 1.92313558 |
107 | Lower limb amyotrophy (HP:0007210) | 1.91246968 |
108 | Abnormality of complement system (HP:0005339) | 1.90198660 |
109 | Distal lower limb muscle weakness (HP:0009053) | 1.89951674 |
110 | Termporal pattern (HP:0011008) | 1.88759087 |
111 | Insidious onset (HP:0003587) | 1.88759087 |
112 | Protrusio acetabuli (HP:0003179) | 1.87603919 |
113 | Dysmetric saccades (HP:0000641) | 1.87433982 |
114 | Spondylolisthesis (HP:0003302) | 1.87092702 |
115 | Polyphagia (HP:0002591) | 1.86305890 |
116 | Increased serum ferritin (HP:0003281) | 1.85880258 |
117 | Pulmonary embolism (HP:0002204) | 1.85484625 |
118 | Mitral stenosis (HP:0001718) | 1.85071630 |
119 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.84805989 |
120 | Polycythemia (HP:0001901) | 1.84670090 |
121 | Neuronal loss in central nervous system (HP:0002529) | 1.84639277 |
122 | Hematochezia (HP:0002573) | 1.84511428 |
123 | Pheochromocytoma (HP:0002666) | 1.84207254 |
124 | Long toe (HP:0010511) | 1.82468127 |
125 | Petechiae (HP:0000967) | 1.81035923 |
126 | Obstructive sleep apnea (HP:0002870) | 1.80246704 |
127 | Apathy (HP:0000741) | 1.78908425 |
128 | Lower limb muscle weakness (HP:0007340) | 1.77162819 |
129 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.77099776 |
130 | Osteomyelitis (HP:0002754) | 1.76970703 |
131 | Aortic aneurysm (HP:0004942) | 1.76804986 |
132 | Premature loss of primary teeth (HP:0006323) | 1.76415485 |
133 | Pathologic fracture (HP:0002756) | 1.75894481 |
134 | Stereotypic behavior (HP:0000733) | 1.75736539 |
135 | Drooling (HP:0002307) | 1.75408493 |
136 | Excessive salivation (HP:0003781) | 1.75408493 |
137 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.75260293 |
138 | EEG with generalized epileptiform discharges (HP:0011198) | 1.74711321 |
139 | Amyotrophic lateral sclerosis (HP:0007354) | 1.74015874 |
140 | Ankyloglossia (HP:0010296) | 1.73861379 |
141 | Epileptiform EEG discharges (HP:0011182) | 1.73030382 |
142 | Emphysema (HP:0002097) | 1.72721202 |
143 | Acne (HP:0001061) | 1.72612445 |
144 | Abnormality of the peritoneum (HP:0002585) | 1.72164944 |
145 | Rapidly progressive (HP:0003678) | 1.71954532 |
146 | Encephalitis (HP:0002383) | 1.71937886 |
147 | Anxiety (HP:0000739) | 1.71044179 |
148 | Hypsarrhythmia (HP:0002521) | 1.70527934 |
149 | Bone pain (HP:0002653) | 1.70305653 |
150 | Abnormality of the nasal mucosa (HP:0000433) | 1.69839974 |
151 | Spastic gait (HP:0002064) | 1.69423499 |
152 | Broad-based gait (HP:0002136) | 1.69403470 |
153 | Retinal atrophy (HP:0001105) | 1.69364913 |
154 | Complement deficiency (HP:0004431) | 1.69274181 |
155 | Buphthalmos (HP:0000557) | 1.69219076 |
156 | Recurrent viral infections (HP:0004429) | 1.69083364 |
157 | Adrenal overactivity (HP:0002717) | 1.68774005 |
158 | Abnormality of the endocardium (HP:0004306) | 1.68624371 |
159 | Aneurysm (HP:0002617) | 1.68361818 |
160 | Polygenic inheritance (HP:0010982) | 1.68085208 |
161 | Megalencephaly (HP:0001355) | 1.68009252 |
162 | Abnormality of oral frenula (HP:0000190) | 1.67524007 |
163 | Focal dystonia (HP:0004373) | 1.66849634 |
164 | Hyperventilation (HP:0002883) | 1.66090597 |
165 | Restrictive lung disease (HP:0002091) | 1.65495179 |
166 | Disinhibition (HP:0000734) | 1.65494531 |
167 | Akinesia (HP:0002304) | 1.64795027 |
168 | Dysdiadochokinesis (HP:0002075) | 1.64465595 |
169 | Inappropriate behavior (HP:0000719) | 1.63597837 |
170 | Open mouth (HP:0000194) | 1.63051144 |
171 | Dilatation of the ascending aorta (HP:0005111) | 1.62292320 |
172 | Abnormality of binocular vision (HP:0011514) | 1.61897493 |
173 | Diplopia (HP:0000651) | 1.61897493 |
174 | Subacute progressive viral hepatitis (HP:0006572) | 1.60861049 |
175 | Abnormality of the lower motor neuron (HP:0002366) | 1.60626952 |
176 | Abnormality of the corticospinal tract (HP:0002492) | 1.60624113 |
177 | Craniofacial dystonia (HP:0012179) | 1.60048069 |
178 | Scanning speech (HP:0002168) | 1.59424208 |
179 | Exotropia (HP:0000577) | 1.58627739 |
180 | Hyporeflexia of lower limbs (HP:0002600) | 1.58290270 |
181 | Increased circulating renin level (HP:0000848) | 1.57288065 |
182 | Dysmetria (HP:0001310) | 1.57214737 |
183 | Progressive inability to walk (HP:0002505) | 1.57047300 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MARK1 | 3.05710876 |
2 | PRPF4B | 2.91826640 |
3 | MAP3K9 | 2.85043335 |
4 | NTRK3 | 2.37711286 |
5 | TYK2 | 2.34872594 |
6 | BLK | 2.33877455 |
7 | MAP2K3 | 2.26308200 |
8 | TRIB3 | 2.16226857 |
9 | MAP3K3 | 2.11083322 |
10 | MAP4K1 | 2.09700931 |
11 | IRAK4 | 2.09480469 |
12 | MINK1 | 1.97750993 |
13 | NTRK1 | 1.95502744 |
14 | CSK | 1.94264406 |
15 | PRKD3 | 1.80695505 |
16 | ZAP70 | 1.80426315 |
17 | IRAK3 | 1.78612152 |
18 | KSR2 | 1.76580171 |
19 | PAK6 | 1.75623421 |
20 | MAP3K4 | 1.73706019 |
21 | MAP3K14 | 1.70245645 |
22 | CAMKK1 | 1.70222329 |
23 | RIPK1 | 1.65350980 |
24 | MAP3K2 | 1.63850323 |
25 | DAPK2 | 1.63423045 |
26 | PRKCH | 1.56877201 |
27 | ERN1 | 1.49326729 |
28 | MAP3K11 | 1.48574476 |
29 | TBK1 | 1.44570969 |
30 | RET | 1.41313257 |
31 | PAK3 | 1.41273041 |
32 | MAP2K4 | 1.40972994 |
33 | NTRK2 | 1.38235859 |
34 | SIK2 | 1.35725659 |
35 | JAK3 | 1.31095921 |
36 | PDGFRA | 1.29302996 |
37 | EPHA4 | 1.29040820 |
38 | CAMKK2 | 1.25743385 |
39 | MAP3K12 | 1.25551643 |
40 | PRKD2 | 1.18844169 |
41 | FGR | 1.18480427 |
42 | FGFR4 | 1.18188688 |
43 | FRK | 1.16589135 |
44 | SMG1 | 1.16516810 |
45 | TAOK2 | 1.16043408 |
46 | PHKG2 | 1.13176769 |
47 | PHKG1 | 1.13176769 |
48 | JAK1 | 1.11256499 |
49 | PKN2 | 1.10919772 |
50 | CDK5 | 1.08638519 |
51 | HCK | 1.07858802 |
52 | PTK6 | 1.07727755 |
53 | SGK3 | 1.07610605 |
54 | KSR1 | 1.07466890 |
55 | FGFR3 | 1.07390182 |
56 | SIK3 | 1.05435010 |
57 | RIPK4 | 1.04534337 |
58 | IKBKE | 1.04176232 |
59 | MAP3K7 | 1.03622400 |
60 | TNK2 | 1.02430109 |
61 | SCYL2 | 1.00550417 |
62 | MATK | 0.99284224 |
63 | CAMK1G | 0.98538229 |
64 | TYRO3 | 0.97704328 |
65 | LMTK2 | 0.96270339 |
66 | FGFR2 | 0.93340485 |
67 | BTK | 0.92997483 |
68 | CSF1R | 0.92233515 |
69 | DMPK | 0.92047076 |
70 | EPHB1 | 0.91195490 |
71 | TAOK1 | 0.91065158 |
72 | STK38 | 0.90300278 |
73 | SYK | 0.89969301 |
74 | PTK2 | 0.88603562 |
75 | CDK12 | 0.86102128 |
76 | MAP3K13 | 0.85862839 |
77 | SGK494 | 0.84700719 |
78 | SGK223 | 0.84700719 |
79 | MAP3K6 | 0.84537696 |
80 | MAP2K7 | 0.83649863 |
81 | GRK5 | 0.83527683 |
82 | RPS6KA2 | 0.82421555 |
83 | KIT | 0.81749439 |
84 | MAPK7 | 0.80331133 |
85 | TTN | 0.79934574 |
86 | SIK1 | 0.79047076 |
87 | MAPK12 | 0.78974171 |
88 | MARK2 | 0.78673637 |
89 | FER | 0.77579623 |
90 | IRAK2 | 0.77400990 |
91 | GRK7 | 0.77258141 |
92 | IRAK1 | 0.76756216 |
93 | WNK1 | 0.74888877 |
94 | FYN | 0.74813702 |
95 | TGFBR2 | 0.74770303 |
96 | FES | 0.74731856 |
97 | IKBKB | 0.73759007 |
98 | STK11 | 0.71882747 |
99 | EPHA3 | 0.71820770 |
100 | PAK4 | 0.71398067 |
101 | WNK4 | 0.70749731 |
102 | SGK2 | 0.69904394 |
103 | MAP3K1 | 0.69611520 |
104 | PDGFRB | 0.69420153 |
105 | LYN | 0.69159770 |
106 | PDK1 | 0.67083547 |
107 | LCK | 0.66443622 |
108 | PRKG2 | 0.66135027 |
109 | CDC42BPA | 0.65921282 |
110 | JAK2 | 0.65902646 |
111 | LATS2 | 0.64640062 |
112 | MAP2K1 | 0.64560067 |
113 | PRKCZ | 0.64158697 |
114 | PTK2B | 0.64041126 |
115 | BMPR2 | 0.63529773 |
116 | RPS6KC1 | 0.63512793 |
117 | RPS6KL1 | 0.63512793 |
118 | TESK1 | 0.60438370 |
119 | TESK2 | 0.60181742 |
120 | SGK1 | 0.60035830 |
121 | NEK9 | 0.59471758 |
122 | EPHA2 | 0.59184378 |
123 | PRKCG | 0.58063731 |
124 | ARAF | 0.57541296 |
125 | PDPK1 | 0.57510514 |
126 | MOS | 0.56332935 |
127 | PIK3CG | 0.53321946 |
128 | PRKCE | 0.52802277 |
129 | PLK2 | 0.52375732 |
130 | DDR2 | 0.51553097 |
131 | MYLK | 0.51314370 |
132 | YES1 | 0.51291056 |
133 | TRPM7 | 0.50572780 |
134 | PRKD1 | 0.50520047 |
135 | TXK | 0.50445576 |
136 | ALK | 0.50379351 |
137 | RPS6KA6 | 0.50127194 |
138 | LRRK2 | 0.50019032 |
139 | INSRR | 0.49590534 |
140 | MST1R | 0.49145630 |
141 | CHUK | 0.48574952 |
142 | MARK3 | 0.48456484 |
143 | HIPK2 | 0.47455843 |
144 | BMX | 0.47159583 |
145 | ITK | 0.46236329 |
146 | ERBB3 | 0.45998944 |
147 | CAMK2A | 0.45872973 |
148 | UHMK1 | 0.45516429 |
149 | STK10 | 0.43929184 |
150 | CAMK1D | 0.43805900 |
151 | MAPKAPK2 | 0.43752522 |
152 | PRKCQ | 0.43395779 |
153 | CDK14 | 0.43058069 |
154 | SRC | 0.42904750 |
155 | ROCK1 | 0.42288057 |
156 | ICK | 0.41900986 |
157 | GRK6 | 0.40632411 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.37089573 |
2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.36062044 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.22733443 |
4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.05932957 |
5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.87146140 |
6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.81542842 |
7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.77561800 |
8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.64093248 |
9 | GABAergic synapse_Homo sapiens_hsa04727 | 1.63690987 |
10 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.61557509 |
11 | Circadian entrainment_Homo sapiens_hsa04713 | 1.56588416 |
12 | Long-term potentiation_Homo sapiens_hsa04720 | 1.51306131 |
13 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.50850969 |
14 | Malaria_Homo sapiens_hsa05144 | 1.49961415 |
15 | Nicotine addiction_Homo sapiens_hsa05033 | 1.47258665 |
16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.45549528 |
17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44660492 |
18 | Salivary secretion_Homo sapiens_hsa04970 | 1.44115504 |
19 | Olfactory transduction_Homo sapiens_hsa04740 | 1.43919938 |
20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.43641593 |
21 | Insulin secretion_Homo sapiens_hsa04911 | 1.43637514 |
22 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.43221673 |
23 | Morphine addiction_Homo sapiens_hsa05032 | 1.42841643 |
24 | Renin secretion_Homo sapiens_hsa04924 | 1.42080851 |
25 | Allograft rejection_Homo sapiens_hsa05330 | 1.39966750 |
26 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.39738251 |
27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.37886907 |
28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.35793083 |
29 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.33679367 |
30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.33127550 |
31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.32380195 |
32 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.32209498 |
33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.30992224 |
34 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.30017063 |
35 | Pertussis_Homo sapiens_hsa05133 | 1.29512335 |
36 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.28428657 |
37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.25749102 |
38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.25727862 |
39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.24356525 |
40 | Phagosome_Homo sapiens_hsa04145 | 1.23419462 |
41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22149987 |
42 | Influenza A_Homo sapiens_hsa05164 | 1.21715580 |
43 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.21123886 |
44 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.20793214 |
45 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.18740332 |
46 | Hepatitis C_Homo sapiens_hsa05160 | 1.14707538 |
47 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.13960783 |
48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.12069214 |
49 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.10442319 |
50 | Cocaine addiction_Homo sapiens_hsa05030 | 1.10417400 |
51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.08091938 |
52 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06941219 |
53 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.06939318 |
54 | Measles_Homo sapiens_hsa05162 | 1.06337475 |
55 | Glioma_Homo sapiens_hsa05214 | 1.05277185 |
56 | Viral myocarditis_Homo sapiens_hsa05416 | 1.04660403 |
57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.03135809 |
58 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.02786577 |
59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.02696973 |
60 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.01945673 |
61 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.00917761 |
62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00206416 |
63 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.98253592 |
64 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.96728283 |
65 | Salmonella infection_Homo sapiens_hsa05132 | 0.96370732 |
66 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.94633671 |
67 | Legionellosis_Homo sapiens_hsa05134 | 0.93317787 |
68 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.92294906 |
69 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.92156382 |
70 | Axon guidance_Homo sapiens_hsa04360 | 0.91397152 |
71 | Hepatitis B_Homo sapiens_hsa05161 | 0.91242257 |
72 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.91034770 |
73 | Gap junction_Homo sapiens_hsa04540 | 0.90144393 |
74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.89587054 |
75 | Taste transduction_Homo sapiens_hsa04742 | 0.89100325 |
76 | Long-term depression_Homo sapiens_hsa04730 | 0.88982233 |
77 | Bile secretion_Homo sapiens_hsa04976 | 0.87429249 |
78 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.86464789 |
79 | Asthma_Homo sapiens_hsa05310 | 0.86038387 |
80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.85627395 |
81 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85092051 |
82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.84820057 |
83 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.83214491 |
84 | Shigellosis_Homo sapiens_hsa05131 | 0.82978560 |
85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82297219 |
86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81448998 |
87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.81171095 |
88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80936882 |
89 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.79718651 |
90 | Bladder cancer_Homo sapiens_hsa05219 | 0.78196359 |
91 | Apoptosis_Homo sapiens_hsa04210 | 0.77606949 |
92 | Endometrial cancer_Homo sapiens_hsa05213 | 0.77346430 |
93 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.76529339 |
94 | Lysosome_Homo sapiens_hsa04142 | 0.76353316 |
95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74598565 |
96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73992142 |
97 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73875994 |
98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.72639171 |
99 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.71702608 |
100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71678613 |
101 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.69854389 |
102 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.69721477 |
103 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69674083 |
104 | Insulin resistance_Homo sapiens_hsa04931 | 0.68972667 |
105 | Endocytosis_Homo sapiens_hsa04144 | 0.68660051 |
106 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.68622112 |
107 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66324388 |
108 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65338993 |
109 | Melanogenesis_Homo sapiens_hsa04916 | 0.65307700 |
110 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65302297 |
111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62395225 |
112 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61878308 |
113 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59647948 |
114 | Amoebiasis_Homo sapiens_hsa05146 | 0.59587994 |
115 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.59480179 |
116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59367487 |
117 | Platelet activation_Homo sapiens_hsa04611 | 0.59018457 |
118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58363694 |
119 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.58047552 |
120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57985735 |
121 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.57475929 |
122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56798491 |
123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56594847 |
124 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55812260 |
125 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.55359934 |
126 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55336008 |
127 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.55098960 |
128 | Focal adhesion_Homo sapiens_hsa04510 | 0.54921430 |
129 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54247961 |
130 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53780500 |
131 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53436237 |
132 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.53386294 |
133 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53076652 |
134 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.53010350 |
135 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52733961 |
136 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52532596 |
137 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52511525 |
138 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52467826 |
139 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.52273757 |
140 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52215058 |
141 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51309152 |
142 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51303431 |
143 | Prion diseases_Homo sapiens_hsa05020 | 0.50940794 |
144 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.49952072 |
145 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49892388 |
146 | Tuberculosis_Homo sapiens_hsa05152 | 0.49571930 |
147 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49543989 |
148 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.49260188 |
149 | Phototransduction_Homo sapiens_hsa04744 | 0.49207910 |
150 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.49031175 |
151 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.47128978 |